Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07505342 · ClinicalTrials.gov registry record
Remote Assessments and Genetic Determinants of Myotonic Dystrophy
A clinical trial, sponsored by University of Rochester.
- Recruiting
- Registry status
- 1,000
- Enrollment target
NCT07505342 is a clinical trial that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 1,000 participants.
The verdict
NCT07505342 is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The goal of this observational study, conducted in participants' homes and requiring no travel to a study site, is to better understand disease variability in people with myotonic dystrophy type 1 (DM1) and to identify effective ways to measure symptoms. Myotonic dystrophy is one of the most variable diseases. Some people develop symptoms when they are young, others when they are much older. In the same family, some people may have mild problems, while others are strongly affected. The goal of this study is to find out more about what is causing these differences. To accomplish this, investigators will study the effects of DM1 on skeletal and smooth muscles, the heart, and the nervous system. Then, investigators will evaluate genetic differences with a blood sample. * Participants will receive a toolkit in the mail which includes all necessary equipment to participate in the study, including an iPad with video conferencing software. * Then the study team will connect with participants via videoconferencing for medical interview about DM1 symptoms and functional assessments * Participants will have their blood drawn in a lab in their community or using a home draw device, and ship it to us for research genetic analysis * Participants can chose to have their research genetic test result returned to them
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-05-10 |
| Est. Completion | 2030-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07505342
The ClinicalTrials.gov registry entry for NCT07505342 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07505342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07505342 about?
NCT07505342 is a clinical study titled "Remote Assessments and Genetic Determinants of Myotonic Dystrophy". The goal of this observational study, conducted in participants' homes and requiring no travel to a study site, is to better understand disease variability in people with myotonic dystrophy type 1 (DM1) and to identify effective ways to measure symptoms. Myotonic dystrophy is one of the most variab...
What is the current status of trial NCT07505342?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2022-05-10. Estimated completion is 2030-01-01.
Who is sponsoring clinical trial NCT07505342?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.